Latest Tumors Stories
For years, cancer-research scientists have been using two-dimensional petri dish models to study and test potential treatments. But now, a team of scientists have developed a method for 3-D printing living tumors – a development that could revolutionize cancer research.
Johns Hopkins researchers have discovered an unexpected phenomenon in the organs that produce sperm in fruit flies: When a certain kind of stem cell is killed off experimentally, another group of non-stem cells can come out of retirement to replace them.
A group of researchers in China and the US have successfully created a 3D model of a cancerous tumor using a 3D printer.
Comprehensive genomic analysis of low-grade brain tumors sorts them into three categories, one of which has the molecular hallmarks and shortened survival of glioblastoma multiforme, the most lethal of brain tumors.
Researchers studying a rare, always fatal brain tumor in children have found several molecular alterations that drive the cancer.
Patients with cancer of the throat and who are positive for the Human Papilloma virus (HPV+) have a good prognosis, but until now the effect of being HPV+ on the prognosis of tumors located elsewhere in the head and neck was unknown.
Researchers have discovered that microscopic "bubbles" developed at Kansas State University are safe and effective storage lockers for harmful isotopes that emit ionizing radiation for treating tumors.
--First-in-Class CLIA Assay for Detection of Tumor-Specific Gene Amplifications Using Circulating Cell-Free DNA-- BALTIMORE, April 2, 2014 /PRNewswire/ -- Personal Genome Diagnostics
In a series of studies involving 140 American men and women with liver tumors, researchers at Johns Hopkins have used specialized 3-D MRI scans to precisely measure living and dying tumor tissue to quickly show whether highly toxic chemotherapy – delivered directly through a tumor's blood supply – is working.
Experimental drug designed to fight abdominal cancers passes important test SYDNEY, March 18, 2014 /PRNewswire/ -- Novogen Limited [ASX:NRT; NASDAQ:NVGN] and its joint venture company
- A political dynamiter.